A Homeopathic Medicine Number (DIN-HM) is issued to homeopathic medicines in Canada. A DIN (Drug Identification Number) is a number issued by Health Canada to a drug product to be sold in Canada. Having a DIN-HM number is mandatory to sell your homeopathic medicines. Homeopathic medicines are treated differently under the Natural Health Product Regulations because they can contain or be manufactured from substances (Schedule F or Schedule D substances) that are not otherwise regulated under the Natural Health Products Regulations.

Why do homeopathic drugs require regulatory compliance in Canada?

. Homeopathic medicines are treated differently under the Natural Health Product Regulations because they can contain or be manufactured from substances (Schedule F or Schedule D substances) that are not otherwise regulated under the Natural Health Products Regulations. In the event that a product categorised as a drug under the Food and Drugs Act is marketed without a DIN, it does not comply with Health Canada requirements. Having a DIN-HM in Canada informs patients that the homeopathic drug has been made in a way that ensures the product’s quality and the label is comprehensive and correct.

What is the medical criteria for homeopathic drugs?

In Canada, the medicinal ingredients of a homeopathic drug must be found in the homeopathic monograph and one of the homeopathic pharmacopoeias such as the Homeopathic Pharmacopeia of HPUS, European Pharmacopeia (Ph. Eur) among others.

Are there Canadian labeling laws for Homeopathic drugs?

Homeopathic medicine labels must be bilingual (i.e. both in English and in French) because these languages are considered official in Canada. Health Canada regulates these products as a type of Natural Health Product (NHP) and therefore they are subject to similar labelling requirements.

Regulatory Compliance Solutions Homeopathic Products Canada

FDA’s dietary supplement NDI notification guidance overview

How to Comply with the FDA’s NDI Notification Process

Learn how to meet FDA’s new dietary ingredient notification requirements for dietary supplements with new educational tools.

June 13, 2025

Pet supplements and veterinary health products comparison between the U.S. and Canada

Pet Supplements or Veterinary Health Products? USA vs Canada

Compare pet supplements vs veterinary health products to stay compliant in the U.S. and Canada. Know the rules and get expert help to launch successfully.

June 11, 2025

FDA OMUFA FY 2025 fee deadline for OTC manufacturers

FY 2025 OMUFA Fees Due June 22: What You Need to Know

FDA’s FY 2025 OMUFA fees are due June 22 for OTC drug manufacturers and contract facilities. Learn what this means and how to stay compliant.

June 9, 2025

Health Canada Class II NHP workload management criteria and submission rules

Class II NHP submissions: What Health Canada’s new workload rules mean for you

Starting June 9, 2025, Class II NHP submissions will no longer be reviewed just based on the date you filed them. Health Canada is updating how it handles licensing applications by applying a new workload management approach, prioritizing submissions based on intent to sell or manufacture in Canada.

June 9, 2025

Subscribe to global regulatory updates

First Name *

Last Name *

Contact Email *

*Required Fields

Regulatory Compliance Solutions for Homeopathic Medicines in Canada

What is a DIN-HM?

Hear from Some of Our Amazing Clients

Homeopathic Medicine Regulatory Compliance in Canada

Homeopathic Drug Compliance Solutions in Canada

How to Comply with the FDA’s NDI Notification Process

Pet Supplements or Veterinary Health Products? USA vs Canada

FY 2025 OMUFA Fees Due June 22: What You Need to Know

Class II NHP submissions: What Health Canada’s new workload rules mean for you

Subscribe to global regulatory updates

Subscribe to global regulatory updates